bioRxiv · 10.1101/2023.08.03.550647
Recovery of proteasome activity in cells pulse-treated with proteasome inhibitors is independent of DDI2
Abstract
Rapid recovery of proteasome activity may contribute to intrinsic and acquired resistance to FDA-approved proteasome inhibitors. Previous studies have demonstrated that the expression of proteasome genes in cells treated with sub-lethal concentrations of proteasome inhibitors is upregulated by the transcription factor Nrf1 (NFE2L1), which is activated by a DDI2 protease. Here, we demonstrate that the recovery of proteasome activity is DDI2-independent and occurs before transcription of proteasomal genes is upregulated but requires protein translation. Thus, mammalian cells possess an additional DDI2 and transcription-independent pathway for the rapid recovery of proteasome activity after proteasome inhibition.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Ibtisam, I., Kisselev, A. F.. 2023-08-04. Recovery of proteasome activity in cells pulse-treated with proteasome inhibitors is independent of DDI2. https://doi.org/10.1101/2023.08.03.550647
Cite the original work for its findings. Save a collection to share your selection of sources.